Literature DB >> 22248053

The oncogenic role of Yin Yang 1.

Qiang Zhang1, Daniel B Stovall, Kazushi Inoue, Guangchao Sui.   

Abstract

Yin Yang 1 (YY1) is a transcription factor with diverse and complex biological functions. YY1 either activates or represses gene transcription, depending on the stimuli received by the cells and its association with other cellular factors. Since its discovery, a biological role for YY1 in tumor development and progression has been suggested because of its regulatory activities toward multiple cancer-related proteins and signaling pathways and its overexpression in most cancers. In this review, we primarily focus on YY1 studies in cancer research, including the regulation of YY1 as a transcription factor, its activities independent of its DNA binding ability, the functions of its associated proteins, and mechanisms regulating YY1 expression and activities. We also discuss the correlation of YY1 expression with clinical outcomes of cancer patients and its target potential in cancer therapy. Although there is not a complete consensus about the role of YY1 in cancers based on its activities of regulating oncogene and tumor suppressor expression, most of the currently available evidence supports a proliferative or oncogenic role of YY1 in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22248053      PMCID: PMC3386643          DOI: 10.1615/critrevoncog.v16.i3-4.30

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  253 in total

1.  Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function.

Authors:  Susanne Schlisio; Terri Halperin; Miguel Vidal; Joseph R Nevins
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

2.  The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene.

Authors:  Jian Xu; Jing De Zhu; Min Ni; Fang Wan; Jian Ren Gu
Journal:  Cell Res       Date:  2002-09       Impact factor: 25.617

3.  Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2.

Authors:  F S Santiago; H C Lowe; Y V Bobryshev; L M Khachigian
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

4.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

5.  YY1 activates Msx2 gene independent of bone morphogenetic protein signaling.

Authors:  D P Tan; K Nonaka; G H Nuckolls; Y H Liu; R E Maxson; H C Slavkin; L Shum
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

6.  Steroidogenic acute regulatory protein expression in the normal human brain and intracranial tumors.

Authors:  Hyun Joon Kim; Jeong Eun Kim; Myung Ha; Sang Soo Kang; Jong Tae Kim; In Sung Park; Sun Ha Paek; Hee-Won Jung; Dong Gyu Kim; Gyeong Jae Cho; Wan Sung Choi
Journal:  Brain Res       Date:  2003-07-18       Impact factor: 3.252

7.  Modulation of YY1 activity by SAP30.

Authors:  Nu En Huang; Ching Hui Lin; Young Sun Lin; Winston C Y Yu
Journal:  Biochem Biophys Res Commun       Date:  2003-06-20       Impact factor: 3.575

8.  Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3.

Authors:  Steven J Gordon; Shireen Saleque; Barbara K Birshtein
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

9.  EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Authors:  Adrian P Bracken; Diego Pasini; Maria Capra; Elena Prosperini; Elena Colli; Kristian Helin
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

10.  Analysis of the TGF-beta1 promoter polymorphism (C-509T) in patients with chronic periodontitis.

Authors:  A P de Souza; P C Trevilatto; R M Scarel-Caminaga; R B de Brito; S R P Line
Journal:  J Clin Periodontol       Date:  2003-06       Impact factor: 8.728

View more
  62 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

Review 2.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

3.  Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner.

Authors:  Brian L Stauffer; Karen Dockstader; Gloria Russell; Jamie Hijmans; Lisa Walker; Mackenzie Cecil; Kimberly Demos-Davies; Allen Medway; Timothy A McKinsey; Carmen C Sucharov
Journal:  Biochem Biophys Res Commun       Date:  2015-04-29       Impact factor: 3.575

4.  Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.

Authors:  Meimei Wan; Weiwei Huang; Timothy E Kute; Lance D Miller; Qiang Zhang; Heather Hatcher; Jingxuan Wang; Daniel B Stovall; Gregory B Russell; Paul D Cao; Zhiyong Deng; Wei Wang; Qingyuan Zhang; Ming Lei; Suzy V Torti; Steven A Akman; Guangchao Sui
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

5.  CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.

Authors:  Jessica A Carter; Dariusz C Górecki; Charles A Mein; Börje Ljungberg; Sassan Hafizi
Journal:  Epigenetics       Date:  2013-05-24       Impact factor: 4.528

6.  Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription.

Authors:  Mengna Li; Yukun Liu; Yanmei Wei; Chunchun Wu; Hanbing Meng; Weihong Niu; Yao Zhou; Heran Wang; Qiuyuan Wen; Songqing Fan; Zheng Li; Xiayu Li; Jianda Zhou; Ke Cao; Wei Xiong; Zhaoyang Zeng; Xiaoling Li; Yuanzheng Qiu; Guiyuan Li; Ming Zhou
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

7.  YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.

Authors:  Xiaorong Zhou; Weiwei Xian; Jie Zhang; Yiqing Zhu; Xiaoyi Shao; Yu Han; Yue Qi; Xiaoling Ding; Xiaoying Wang
Journal:  Immunology       Date:  2018-08-29       Impact factor: 7.397

8.  High-resolution interrogation of functional elements in the noncoding genome.

Authors:  Neville E Sanjana; Jason Wright; Kaijie Zheng; Ophir Shalem; Pierre Fontanillas; Julia Joung; Christine Cheng; Aviv Regev; Feng Zhang
Journal:  Science       Date:  2016-09-30       Impact factor: 47.728

9.  YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates.

Authors:  Divya Bhaskar Rao; Ponmathi Panneerpandian; Karthik Balakrishnan; Kumaresan Ganesan
Journal:  J Cell Commun Signal       Date:  2021-02-23       Impact factor: 5.782

Review 10.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.